Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Sycamore Partners eyes 2027 London IPO for Boots in potential $8bn+ exit
Sycamore Partners eyes 2027 London IPO for Boots in potential $8bn+ exit Sycamore Partners is exploring a potential London stock market listing for Boots as early as 2027, according to an exclusive report by Reuters. The US private equity firm has held preliminary...
Clearlake Capital’s Feliciano closes in on MLB-record $3.9bn San Diego Padres acquisition
Clearlake Capital's Feliciano closes in on MLB-record $3.9bn San Diego Padres acquisition José E Feliciano, co-founder of Santa Monica-based private equity firm Clearlake Capital, is nearing a $3.9bn acquisition of the San Diego Padres, according to reports by the...
Polymarket seeks $400m raise at $15bn valuation as trading volumes surge
Polymarket seeks $400m raise at $15bn valuation as trading volumes surge New investors are in talks to deploy $400m into Polymarket, the prediction market platform, at a $15bn valuation, following a $600m raise completed last month, according to Bloomberg. The fresh...